Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

注射用两性霉素B脂质体 - NMPA Drug Approval Details

Approvals/NMPA/Amphotericin B Liposome for Injection

Approved

化学药品

Amphotericin B Liposome for Injection

Unknown🇨🇳 National Medical Products Administration

Approval Date: Feb 20, 2025
Approval ID: 8hPzCeyVZ57
Company: Unknown
Type: 化学药品

Approval Details

Approval Id: 8hPzCeyVZ57
Approval Number: 国药准字HC20250001
Generic Name: 注射用两性霉素B脂质体
Generic Name En: Amphotericin B Liposome for Injection
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 50mg（5万单位）
Reg Date: 2025-02-20
Expired Date: 2030-02-19
Production Company Address: 中国台湾台中市大甲区日南里工九路27号

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Feb 20, 2025

Approval ID

8hPzCeyVZ57

Type

化学药品

Back to NMPA Approvals